Topspin Medical
1
30M
1
0.05
1
- Areas of investment
Summary
Topspin Medical is the famous Corporate Investor, which was founded in 1999. The leading representative office of defined Corporate Investor is situated in the Lod. The fund was located in Asia if to be more exact in Israel.
The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are venBio Partners, The Column Group, OrbiMed.
Among the most popular portfolio startups of the fund, we may highlight Seragon Pharmaceuticals. Among the most successful fund investment fields, there are Health Care, Biotechnology. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
The important activity for fund was in 2013. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.05
- Investments by industry
- Biotechnology (1)
- Bioinformatics (1)
- Pharmaceutical (1)
- Health Care (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 725M
- Group Appearance index
- 1.00
- Avg. company exit year
- 1
- Avg. multiplicator
- 24.17
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Seragon Pharmaceuticals | 16 Oct 2013 | Biotechnology, Health Care, Pharmaceutical, Bioinformatics | Early Stage Venture | 30M | United States, California, Irvine |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.